Purpose
|
Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries. Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.
|
Characteristics
|
Tradename: MILTEX Source of Compound: synthetic, D-18506, HDPC Target: Akt inhibitor, PI3K inhibitor, PKC inhibitor Receptor: Akt, PI3K, PKC Status: INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C21H46NO4P.xH2O
|
Solubility
|
Water:82 mg/mL, Ethanol: 82 mg/mL
|